Barbara Klughammer

Title: Barbara Klughammer: Innovator in Cancer Diagnostics

Introduction

Barbara Klughammer is a prominent inventor based in Rheinfelden, Germany. She has made significant contributions to the field of cancer diagnostics, particularly in the assessment of solid tumors. With a total of 2 patents, her work has the potential to improve patient outcomes in cancer treatment.

Latest Patents

Her latest patents include innovative methods for mutation testing, which involve improved techniques for assessing the status of solid tumor cancer in subjects by detecting tumor-associated mutations in their blood. Additionally, she has developed a predictive marker for EGFR inhibitor treatment, providing a biomarker that predicts the clinical benefit of EGFR inhibitor treatment in cancer patients.

Career Highlights

Throughout her career, Barbara has worked with notable companies such as Roche Molecular Systems, Inc. and Hoffmann-La Roche Inc. Her expertise in molecular diagnostics has positioned her as a key player in the development of advanced cancer treatment methodologies.

Collaborations

Barbara has collaborated with esteemed colleagues, including Peter Meldgaard and Boe Sorensen, to further enhance the impact of her innovations in the medical field.

Conclusion

Barbara Klughammer's contributions to cancer diagnostics through her patents and collaborations highlight her role as an influential inventor in the healthcare industry. Her work continues to pave the way for advancements in cancer treatment and patient care.